Research Correspondence

DOI: 10.4244/EIJ-D-24-00599

Outcomes of high-risk PCI assisted by VA-ECMO with local anaesthesia

Alexander M. Griffioen1, MD; Marleen H. van Wely1, MD; Lokien X. van Nunen1, MD, PhD; Stijn C.H. van den Oord2, MD, PhD; Herbert B. van Wetten1, MD; Sytse F. de Jong1, MSc; Peter Damman1, MD, PhD; Niels van Royen1, MD, PhD; Robert Jan M. van Geuns1, MD, PhD

High-risk percutaneous coronary intervention (PCI) is increasingly performed because of an ageing population with a high incidence of comorbidities and high surgical risk scores1. Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is an effective method to prevent haemodynamic deterioration during high-risk PCI. VA-ECMO is mainly surgically deployed under general anaesthesia. New developments have facilitated a completely percutaneous insertion of VA-ECMO with local anaesthesia, reducing operating team sizes and enabling early mobilisation after PCI without the need for intensive care unit (ICU) admission.

This study is a single-centre registry that included all patients undergoing high-risk PCI with VA-ECMO support between January 2020 and March 2024 at the Radboud University Medical Center in Nijmegen, the Netherlands. The study design has been previously described in detail2. Preprocedural angiographic computed tomography (CT) scans were performed in all cases to assess peripheral access. The procedural set-up for VA-ECMO (de)cannulation was similar for all cases (Supplementary Figure 1, Moving image 1).

Procedural success was defined as successful revascularisation (final residual stenosis <50% with a Thrombolysis in Myocardial Infarction flow grade 3, achieved in at...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 21 Number 7
Apr 7, 2025
Volume 21 Number 7
View full issue


Key metrics

Suggested by Cory

Editorial

10.4244/EIJ-E-23-00029 Aug 21, 2023
VA-ECMO in cardiogenic shock: is the road closed or open?
Thiele H and Freund A
free

Research Correspondence

10.4244/EIJ-D-23-01046 Apr 15, 2024
Feasibility and safety of transcaval venoarterial extracorporeal membrane oxygenation in severe cardiogenic shock
Giustino G et al
free
Trending articles
95.7

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
65.05

State-of-the-Art

10.4244/EIJ-D-24-00992 Sep 15, 2025
Antithrombotic therapy in complex percutaneous coronary intervention
Castiello D et al
free
56.1

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
56.1

Original Research

10.4244/EIJ-D-25-00331 Jul 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
35.45

State-of-the-Art

10.4244/EIJ-D-23-00448 Jan 15, 2024
Coronary spasm and vasomotor dysfunction as a cause of MINOCA
Yaker ZS et al
free
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved